经前烦躁障碍与健康女性月经周期中皮质醇觉醒反应的变化
该纵向研究纳入30例经前烦躁障碍(PMDD)患者与29名健康对照,在围排卵期与经前期采集唾液测皮质醇觉醒反应(CAR),并行[11C]DASB PET测5-HTT结合,用汉密尔顿抑郁量表评估抑郁症状。结果发现组别与周期相位对皮质醇峰值浓度存在交互效应,经前期皮质醇峰值与中脑5-HTT BPND及抑郁症状呈负相关。
要点
- PMDD患者围排卵期皮质醇峰值较健康对照减弱,健康对照显示跨周期可塑性变化。
- 经前期皮质醇峰值与中脑5-HTT BPND负相关(r=-0.34,p<0.01,R2=0.12)。
- 经前期皮质醇峰值与抑郁症状负相关(r=-0.30,p=0.02,R2=0.09)。
核心结论
- PMDD患者围排卵期皮质醇峰值较健康对照减弱,健康对照显示跨月经周期可塑性变化。
- 结果提示应激系统与5-羟色胺系统之间存在相互作用,并与经前期抑郁症状严重程度相关。
研究设计与样本
- 纵向研究纳入30例PMDD患者与29名健康对照。
- 在围排卵期与经前期各采集3份唾液测CAR(觉醒、+30分钟、+60分钟)及5份测昼夜皮质醇斜率(09:00、12:00、15:00、18:00、21:00)。
- 以[11C]DASB PET测量5-HTT不可置换结合潜能(BPND),用汉密尔顿抑郁量表评估抑郁症状。
- 采用线性混合效应模型、独立样本t检验、混合方差分析与Spearman秩相关分析关联。
主要发现
- 组别与周期相位对皮质醇峰值浓度存在显著交互效应(估计值=0.78,p=0.05,d=0.62,95%CI:[0.01,1.56])。
- 校正觉醒皮质醇浓度后交互效应仍显著(估计值=0.90,p=0.02,d=0.77,95%CI:[0.15,1.66])。
- 经前期皮质醇峰值与中脑5-HTT BPND负相关(r=-0.34,p<0.01,R2=0.12)。
- 经前期皮质醇峰值与抑郁症状负相关(r=-0.30,p=0.02,R2=0.09)。
临床怎么用
- 对PMDD患者评估皮质醇觉醒反应时需结合月经周期相位解读。
- 经前期皮质醇峰值减弱可能提示应激与5-羟色胺系统交互及抑郁症状严重度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Research suggests there are alterations in the cortisol awakening response (CAR) in patients with premenstrual dysphoric disorder (PMDD), as demonstrated by delayed cortisol peaks and flatter diurnal cortisol slopes compared to healthy controls. While inconsistent, previous work also demonstrates a relation between alterations in CAR, prefrontal serotonin transporter (5-HTT) binding and severity of depressive symptoms. AIMS: This longitudinal study explores CAR in relation to midbrain and prefrontal 5-HTT binding and depressive symptoms in patients with PMDD and in healthy controls across the menstrual cycle. METHOD: Thirty patients with PMDD and 29 controls each provided 3 saliva samples for assessment of CAR (awakening, +30 min, +60 min) and 5 to assess the diurnal cortisol slope (09.00, 12.00, 15.00, 18.00, 21.00 h) during the periovulatory and premenstrual phases. [11C]DASB positron emission tomography scans were performed to measure 5-HTT non-displaceable binding potential (BPND). Depressive symptoms were assessed using the Hamilton Depression Rating Scale. Associations between cortisol measures, 5-HTT BPND and depressive symptoms were examined using linear mixed-effects models, independent t-tests, mixed analysis of variance (ANOVA) and Spearman rank correlations. RESULTS: A significant interaction effect between group and cycle phase was found for cortisol peak concentrations (estimate = 0.78, p = 0.05, d = 0.62, 95% CI: [0.01, 1.56]; and corrected for awakening cortisol concentration: estimate = 0.90, p = 0.02, d = 0.77, 95% CI: [0.15, 1.66]). Cortisol peak concentrations correlated negatively with both midbrain 5-HTT BPND (r = -0.34, p < 0.01, R2 = 0.12) and depressive symptoms (r = -0.30, p = 0.02, R2 = 0.09) during the premenstrual phase. CONCLUSIONS: Patients with PMDD showed attenuated cortisol peaks in the periovulatory phase compared with healthy controls, who demonstrated plastic changes across the cycle. Results point towards an interplay between the stress and the serotonergic system, as well as to the severity of depressive symptoms during the premenstrual phase.
引用
- Hoffmann K, Zsido RG, Villringer A, et al. Exploring the cortisol awakening response in premenstrual dysphoric disorder and in healthy females across the menstrual cycle. Br J Psychiatry. 2025. PMID: 41208395. doi:10.1192/bjp.2025.10432
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。